You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Routine antibiotics given for uncomplicated severe acute malnutrition reduce mortality and improve nutritional recovery
  1. Marko Kerac
  1. Department of Epidemiology and Public Health, Leonard Cheshire Disability and Inclusive Development Centre, University College London, London, UK
  1. Correspondence to : Dr Marko Kerac
    Department of Epidemiology and Public Health, Leonard Cheshire Disability and Inclusive Development Centre, University College London, 1-19 Torrington Place, London WC1E 6BT, UK; marko.kerac{at}gmail.com

http://dx.doi.org/10.1136/eb-2013-101312

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Trehan I, Goldbach HS, LaGrone LN, et al. Antibiotics as part of the management of severe acute malnutrition. N Engl J Med 2013;368:425–35.OpenUrlCrossRefPubMedWeb of Science

    Context

    Severe acute malnutrition (SAM) causes over one million child deaths per year.1 Community Management of Acute Malnutrition (CMAM) classifies clinically stable children with good appetite as having ‘uncomplicated SAM’. They are treated as outpatients using specially formulated ready-to-use therapeutic foods.2 Many programmes also give routine antibiotics. This is not evidence-based, but a continuation from old, inpatient-only, treatment approaches where children often presented late and were, hence, much sicker on admission. Since antibiotics also have costs and potential risks, this study evaluated their use in uncomplicated SAM.

    Methods

    This is a double-blind, placebo-controlled, randomised trial examining two different oral antibiotics, amoxicillin and cefdinir, …

    View Full Text

    Footnotes

    • Competing interests MK attended the 2012 WHO expert meeting on SAM3, and received funding for coauthoring an unrelated systematic review (on infant SAM) with IT and MJM.